AAN 2025 Highlights: MS Remyelina...

AAN 2025 Highlights: MS Remyelination, AI Wearables, and Breakthroughs in Migraine and Alzheimer’s

Curie: Healthcare in Focus por Curie
T1 · E27
15 abr 2025
06:55

Notas del episodio

In this special Curie episode, Matt covers the biggest clinical updates from the 2025 American Academy of Neurology Annual Meeting. Learn how CNM-Au8 is showing real signs of remyelination in MS, why AXS-05 may be the next approved treatment for Alzheimer’s agitation, and how Vyepti is delivering long-term migraine relief. We also spotlight Mi-Helper, a noninvasive cooling device for migraines, and the Felix NeuroAI wearable, a smart wristband reducing essential tremor through AI-guided stimulation. Tune in for expert quotes, clinical relevance, and cutting-edge neurology updates.

Palabras clave

AAN
American Academy of Neurology
Multiple sclerosis
Alzheimer’s
migraine
Vyepti